EUCTR2016-002324-92-FR进行中（未招募）1 期
Efficiency of Levamisole for Maintaining Remission After the First Flare of Steroid Sensitive Nephrotic Syndrome in Children (NEPHROVIR3) - NEPHROVIR-3
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 156
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 156
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Efficacy of Levamisol in Treating COVID-19IRCT20201124049480N1Artesh University of Medical Sciences365
招募中
2 期
Evaluation of Levamisole efficacy in treatment of Covid-19IRCT20190810044500N7Yazd University of Medical Sciences50
进行中（未招募）
1 期
Prevention of the return of nephrotic syndrom in children by adding levamisole to prednisolone treatmentEUCTR2017-001025-41-BEAmsterdam University Medical Center, location AMC92
招募中
3 期
Prevention of relapses with Levamisole as adjuvant therapy to corticosteroids in children with first episode of idiopathic nephrotic syndrome.NL-OMON55651Academisch Medisch Centrum87
招募中
3 期
Prevention of the return of nephrotic syndrom in children by adding levamisole to prednisolone treatment2024-517467-23-00Amsterdam UMC Stichting87